Day: June 25, 2026

Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit

Findings highlight RedTail’s potential to overcome historical limitations of T-cell engagers in solid tumors through tumor-specific, localized expressionSAN DIEGO, June...

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor...

Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress

Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled trial...

Digital Health Market Size to Reach USD 1,830.4 Billion by 2033, Driven by Rising Adoption of Telehealth, mHealth, AI-Based Solutions, and Connected Healthcare Technologies: Grand View Research, Inc.

JellyFil Releases 2026 Supplement Facts Including Full Ingredients Breakdown, Package Pricing, and Money-Back Guarantee Terms

The US-distributed gummy dietary supplement brand discloses current ingredient formulation, 2026 pricing tiers, refund eligibility terms, and official customer service...

JellyFil Releases 2026 Supplement Facts Including Full Ingredients Breakdown, Package Pricing, and Money-Back Guarantee Terms

The US-distributed gummy dietary supplement brand discloses current ingredient formulation, 2026 pricing tiers, refund eligibility terms, and official customer service...

error: Content is protected !!